Interest in testosterone replacement therapy keeps climbing, and the TRAVERSE trial remains the largest randomized test of its cardiovascular safety. Here is what men considering treatment and their doctors need to know about the findings.
What Is the TRAVERSE Trial and Why Does It Matter?
The TRAVERSE trial is the largest randomized controlled study designed to test whether testosterone replacement therapy raises the risk of major heart problems in men with confirmed hypogonadism. Results were published in 2023 in the New England Journal of Medicine.
Researchers enrolled 5...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free